<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04908839</url>
  </required_header>
  <id_info>
    <org_study_id>MDL _2021_12</org_study_id>
    <nct_id>NCT04908839</nct_id>
  </id_info>
  <brief_title>Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)</brief_title>
  <acronym>QOLOTOSC</acronym>
  <official_title>Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inclusion (J0):&#xD;
&#xD;
        -  Audiometry (as part of the treatment, only for cases)&#xD;
&#xD;
        -  Clinical evaluation (within the framework of care, only for cases)&#xD;
&#xD;
        -  Passage of the French version of the SPOT-25 questionnaire&#xD;
&#xD;
      Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the&#xD;
      SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or&#xD;
      hospitalization, if this occurs within a compatible time frame.&#xD;
&#xD;
      Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the&#xD;
      French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a&#xD;
      consultation or hospitalization, if this occurs within a compatible time frame.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion (J0):&#xD;
&#xD;
        -  Audiometry (as part of the treatment, only for cases)&#xD;
&#xD;
        -  Clinical evaluation (within the framework of care, only for cases)&#xD;
&#xD;
        -  Passage of the French version of the SPOT-25 questionnaire&#xD;
&#xD;
      Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the&#xD;
      SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or&#xD;
      hospitalization, if this occurs within a compatible time frame.&#xD;
&#xD;
      Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the&#xD;
      French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a&#xD;
      consultation or hospitalization, if this occurs within a compatible time frame.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the total score of cases and controls for the French version of the SPOT-25 questionnaire</measure>
    <time_frame>1 DAY</time_frame>
    <description>The SPOT-25 questionnaire includes 25 items and can be divided into 4 subscores: hearing function (items 1-10), tinnitus (items 11-13), mental condition (items 14-19), and social restrictions (items 20-24). In addition, 1 item focuses on the general evaluation of the impact of otosclerosis on HRQOL (item 25). Each question needs to be rated on a six-point ordinal scale from 0 (i.e., no impact) to 5 (i.e., most severe impact), depending on the level of inconvenience or frequency of symptoms.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Otosclerosis</condition>
  <arm_group>
    <arm_group_label>case: patient with otosclerosis</arm_group_label>
    <description>Diagnosis of otosclerosis with indication for primary stapedial surgery by the combination of arguments</description>
  </arm_group>
  <arm_group>
    <arm_group_label>case: otosclerosis patient with surgery</arm_group_label>
    <description>otosclerosis patient with surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controle: Absence of known otological pathology</arm_group_label>
    <description>Absence of known otological pathology</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>spot-25 questionnaire</intervention_name>
    <description>spot-25 questionnaire</description>
    <arm_group_label>case: otosclerosis patient with surgery</arm_group_label>
    <arm_group_label>case: patient with otosclerosis</arm_group_label>
    <arm_group_label>controle: Absence of known otological pathology</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with otosclerosis and person with a known Absence of otological pathology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged&gt; 18 years&#xD;
&#xD;
          -  Diagnosis of otosclerosis with indication for primary stapes surgery by the&#xD;
             combination of the arguments:&#xD;
&#xD;
               -  Clinical: normal eardrum and audiometry revealing conductive or mixed hearing&#xD;
                  loss with audiometric Rinne of&gt; 15 dB and absence of stapedial reflex.&#xD;
&#xD;
               -  Radiological: otosclerotic foci on preoperative CT scan&#xD;
&#xD;
          -  Non-opposition to participating in the study&#xD;
&#xD;
          -  Good understanding of French&#xD;
&#xD;
          -  Affiliate or beneficiary of a health insurance plan&#xD;
&#xD;
        Inclusion criteria for witnesses:&#xD;
&#xD;
          -  Person aged&gt; 18 years&#xD;
&#xD;
          -  Absence of known otological pathology&#xD;
&#xD;
          -  Without otological surgical history&#xD;
&#xD;
          -  Non-opposition to participating in the study&#xD;
&#xD;
          -  Good understanding of French&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Comorbidity that may interfere with the interpretation of results&#xD;
&#xD;
          -  History of stapes surgery&#xD;
&#xD;
          -  Person benefiting from a legal protection measure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>amélie YAVCHITZ</last_name>
    <phone>0148036454</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amélie YAvchitz</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Amélie Yavchitz, MD, PhD</last_name>
      <phone>+33148036454</phone>
      <email>ayavchitz@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>May Daval, MD, PhD</last_name>
      <phone>0148036988</phone>
      <email>mdaval@for.paris</email>
    </contact_backup>
    <investigator>
      <last_name>Mary Daval, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SPOT-25</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

